Comparing blood thinners to prevent clots after weight-loss surgery
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study compares two blood-thinning medications, rivaroxaban (a pill) and enoxaparin (a shot), to prevent dangerous blood clots after weight-loss surgery. If you are scheduled for bariatric surgery, this trial could help determine which approach works better for someone like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 60 years old.
- Your body mass index (BMI) is between 35 and 50.
- You are healthy enough for surgery (classified as ASA I to III).
- You do not have a serious heart condition, chronic kidney failure, liver cirrhosis, or a major psychological disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different schedules of bemiparin (a blood thinner) to prevent dangerous blood clots after surgery in people with very high body weight. It may help find the safest and most effective dose/timing for clot prevention around the time of surgery.
This trial compares two blood thinners, Rivaroxaban (a pill) and Enoxaparin (a shot), to see which works better at preventing dangerous blood clots in the legs after emergency abdominal surgery. It may help you if you need to stay in bed for more than a day after your operation.
This trial tests whether a blood-thinner medication (tinzaparin) can safely prevent dangerous blood clots in people with obesity who are having weight-loss surgery. The study happens at St Vincent's University Hospital in Dublin, Ireland.
This study compares giving enoxaparin (a blood thinner) in two different spots on the body (belly vs. thigh) for patients with severe obesity who need to prevent blood clots after surgery or hospital stay. The goal is to see which injection site works best.
This trial compares two blood-thinning strategies after leg artery surgery or angioplasty to prevent dangerous blood clots. Participants will receive either rivaroxaban plus aspirin or aspirin alone, and researchers will monitor for clots over 30 days.
This trial compares two ways to prevent blood clots after open heart surgery: a “direct oral” blood thinner pill versus warfarin (a vitamin K antagonist). It may help find the safest and most effective option for people who develop atrial fibrillation after surgery.
Hear when a new Bariatric Surgery Candidate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.